Drug Trial Radar · NCT00529087
Study Evaluating Subcutaneous MOA-728 for the Treatment of Opioid-Induced Constipation (OIC) in Subjects With Chronic Non-Malignant Pain
Last checked: Nov 19, 2026Latest source record: Nov 25, 2019 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
460
Actual
Start
Aug 2007
Primary completion
Dec 2008
Study completion Dec 2008
Sponsor
- Lead sponsor
- Bausch Health Americas, Inc.Industry
- Sponsor type
- Industry
- Collaborators
- Progenics Pharmaceuticals, Inc.
- First posted
- Sep 14, 2007
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Quadruple (participant, care provider, investigator, outcomes assessor)
- Primary purpose
- Treatment
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The primary purpose of the protocol is to evaluate the safety, efficacy, and tolerability of subcutaneous MOA-728 versus placebo in subjects with chronic non-malignant pain who have Opioid-Induced Constipation (OIC).
Conditions
- Constipation
Interventions
N-methylnaltrexone bromide (MOA-728)Drug
Subcutaneous
placeboOther
placebo
Primary outcomes
What the sponsor says the trial is designed to measure.
- Percentage of Patients Having a Rescue-free Bowel Movement (RFBM) Within 4 Hours of the First DoseTime frame: up to 4 hours
- Percentage of Active Injections Resulting in Any Rescue-free Bowel Movement (RFBM) Within 4 Hours of Injection During the Double-blind PeriodTime frame: 4 weeks
Locations
78 sites in 1 country. Site status is shown where the registry gives one.
Site not named
Mobile, Alabama
Site not named
Mobile, Alabama
Site not named
Sun City, Arizona
Site not named
Tucson, Arizona
Site not named
Tucson, Arizona
Site not named
Hot Springs, Arkansas
Site not named
Anaheim, California
Site not named
Garden Grove, California
Site not named
Hawaiian Gardens, California
Site not named
Long Beach, California
Site not named
Los Angeles, California
Site not named
San Diego, California
Site not named
Brandon, Florida
Site not named
Cheifland, Florida
Site not named
Clearwater, Florida
Site not named
Gainesville, Florida
Site not named
Jacksonville, Florida
Site not named
Jupiter, Florida
Site not named
Largo, Florida
Site not named
Miami, Florida
Site not named
Naples, Florida
Site not named
Ocala, Florida
Site not named
Ocala, Florida
Site not named
Orlando, Florida
Site not named
Ormond Beach, Florida
Site not named
Spring Hill, Florida
Site not named
Tampa, Florida
Site not named
West Palm Beach, Florida
Site not named
Winter Park, Florida
Site not named
Atlanta, Georgia
Site not named
Marietta, Georgia
Site not named
Stockbridge, Georgia
Site not named
Chicago, Illinois
Site not named
DeKalb, Illinois
Site not named
Avon, Indiana
Site not named
Indianapolis, Indiana
Site not named
West Des Moines, Iowa
Site not named
Shreveport, Louisiana
Site not named
Sunset, Louisiana
Site not named
Elkridge, Maryland
Showing 40 of 78 sites, US sites first. The full list is on the registry record.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.